In line, both experimental models and clinical observations from others and our group suggest that IgM may have an important role in MASLD, limiting hepatic inflammation during hyperlipidaemia [20, 21, 22]. Here, CD40LG is linked to metabolic dysfunction-associated steatotic liver disease.